[Molecular biology methods in cancer medicine: options beyond steel instrument, ray and chemotherapy].
Paukstadt
Waldtraud
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000628:therapy; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D018450:Disease Progression; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D000077146:Irinotecan; D008297:Male; D009154:Mutation; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy; D012106:Research; D018139:Simplexvirus / Q000235:genetics / Q000276:immunology; D000068878:Trastuzumab; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000077146:Irinotecan; D000068878:Trastuzumab; D002166:Camptothecin